Home > Insider Trading > Ocugen Inc. > Profile

Ocugen Inc. (OCGN)

Sector: Biological Products, (No Disgnostic Substances)

Related Insiders

Sanjay Subramanian, Chief Financial Officer, 2021-02-01
Vijay Tammara, Senior Vice President, 2021-01-04
Uday Kompella, Director, 2021-01-04

Sanjay Subramanian, Chief Financial Officer, 2021-02-01
Vijay Tammara, Senior Vice President, 2021-01-04
Uday Kompella, Director, 2021-01-04
Suha Taspolatoglu, Director, 2021-01-04
Shankar Musunuri, Chief Executive Officer, 2021-01-04
Ramesh Kumar, Director, 2021-01-04
Prabhavathi Fernandes, Director, 2021-01-04
Manish Potti, Director, 2021-01-04
Kirsten Castillo, Director, 2021-01-04
Junge Zhang, Director, 2021-01-04
Rasappa Arumugham, Chief Scientific Officer, 2020-05-07
Daniel Jorgensen, Chief Medical Officer, 2020-05-07
Kelly Beck, Vice President, 2020-05-07
Frank Leo, Director, 2020-01-04
C. David Hood, Director, 2019-07-22
Ltd Estates Wilmslow, Large Shareholder, 2019-02-11
Michael Lewis, Director, 2019-02-11
Kevin Rakin, Director, 2019-02-11
Intrexon Corp, Large Shareholder, 2019-01-15
J Randal Kirk, Large Shareholder, 2019-01-15
E Lynne Kelley, Chief Medical Officer, 2018-10-03
Richard Stephen Kennedy, Chief Operating Officer, 2018-10-03
Donald Haut, Chief Business Officer, 2018-10-03
I Jonathan Lieber, Chief Financial Officer, 2018-10-03
Adam Gridley, President And Ceo, 2018-10-03
N David Gill, Director, 2018-06-19
Garheng Kong, Director, 2018-06-19
J Joshua Baltzell, Director, 2018-06-19
John Johnson, Director, 2018-06-19
B. Susan Washer, Director, 2018-04-18
Gloria Matthews, Chief Medical Officer, 2017-02-15
Split Rock Partners Ii Management, Llc, Large Shareholder, 2017-01-27
Split Rock Partners Ii, Lp, Large Shareholder, 2017-01-27
Kevin Mcardle, Chief Financial Officer, 2015-02-27
Michael Powell, Large Shareholder, 2014-12-10
James Healy, Large Shareholder, 2014-12-10
Srinivas Akkaraju, Large Shareholder, 2014-12-10
Sofinnova Venture Partners Viii, L.p., Large Shareholder, 2014-12-10
Sofinnova Management Viii, L.l.c., Large Shareholder, 2014-12-10
Anand Mehra, Large Shareholder, 2014-12-10
Nancy Lynch, Chief Medical Officer, 2014-12-03

Show All Insiders (41)

Hedge Fund Holdings

Filing Period:

Last updated on November 20, 2019, 10:00 am based on SEC 13F filings Last update: November 20, 2019, 10:00 am

No.	Hedge Fund	Shares	Value (x$1000)	Activity	% Port
1.	Millennium Management Israel Englander	0	$0		0%
2.	Palo Alto Investors William Leland Edwards	0	$0		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Castillo	$0.31	75,000	Director	75,000	2020-05-28	Filing
Musunuri	$0.35	143,000	Officer, Director	406,000	2019-12-12	Filing
Musunuri	$0.41	263,000	Officer, Director	263,000	2019-12-11	Filing
Zhang	$0.44	220,000	Director	818,578	2019-12-04	Filing
Zhang	$0.41	98,500	Director	133,578	2019-11-18	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Kirk	$0.15	345,897	Large Shareholder	1,692,366	2019-01-15	Filing
Kirk	$0.16	400,507	Large Shareholder	2,038,263	2019-01-14	Filing
Kirk	$0.17	251,800	Large Shareholder	2,438,770	2019-01-11	Filing
Sofinnova	$11.00	1,002	Large Shareholder	1,585,650	2014-12-08	Filing
Wilmslow	$11.00	792	Large Shareholder	1,539,572	2014-12-08	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value (x$1000)	% Port
1.	Abingworth Llp	7,111	$13	0%